MAZE Maze Therapeutics, Inc.
MAZE Maze Therapeutics, Inc.
Healthcare · Biotechnology
Market read
Scan convergence 1 scan as of 2026-10-23 1 neutral converging
POC $26.57 · VWAP $32.36 · -4.2% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster CEO, President + 2 others sold $2.9M, Aug 31–Sep 8
Coverage
1 watchlist
MAZE Price Structure
Loading timeframes…
Peers
Every watchlist MAZE belongs to, members best 30-day change first — MAZE highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Reported the quarter ending 2026-06-30: diluted EPS -$0.76, net income -$45M (SEC filing). Across the print the stock moved +1.3% (close before → first close after).
full note →Against street estimates
How MAZE's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
News (last pull)
Headlines about MAZE from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 31 days ago · Sep 22
- Maze Therapeutics Inc Stock Price Today | NASDAQ: MAZE Live - Investing.com
- Maze Therapeutics, Inc. (MAZE) Earnings Call Transcript & Summary
- Maze Therapeutics Earnings: $495M Cash, Expected 2029 Runway | MAZE Stock News
- Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights | Maze Therapeutics
- Maze Therapeutics, Inc. Common Stock (MAZE) Live Share Price, Invest From India
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
MAZE research tape
23 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.